Acebutolol Hydrochloride
Product Images NDC 10135-630

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acebutolol Hydrochloride (NDC 10135-630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Following Structural Formula For Acebutolol HCl, Usp Is A Selective, Hydrophilic Beta-adrenoreceptor Blocking Agent With Mild Intrinsic Sympathomimetic Activity For Use In Treating Patients With Hypertension And Ventricular Arrhythmias. It Is Marketed In Capsule Form For Oral Administration. Acebutolol HCl Capsules, Usp Are Provided In Two Dosage Strengths Which Contain 200 mg Or 400 mg Of Acebutolol As The Hydrochloride Salt. The Inactive Ingredients Present Are D&c Red 28, D&c Yellow 10, Fd&c Blue 1, Fd&c Red 40, Gelatin, Maize Starch, Povidone, Stearic Acid And Titanium Dioxide. (Acebutolol Hydrochloride Capsules 01)

The Following Structural Formula For Acebutolol HCl, Usp Is A Selective, Hydrophilic Beta-adrenoreceptor Blocking Agent With Mild Intrinsic Sympathomimetic Activity For Use In Treating Patients With Hypertension And Ventricular Arrhythmias. It Is Marketed In Capsule Form For Oral Administration. Acebutolol HCl Capsules, Usp Are Provided In Two Dosage Strengths Which Contain 200 mg Or 400 mg Of Acebutolol As The Hydrochloride Salt. The Inactive Ingredients Present Are D&c Red 28, D&c Yellow 10, Fd&c Blue 1, Fd&c Red 40, Gelatin, Maize Starch, Povidone, Stearic Acid And Titanium Dioxide. (Acebutolol Hydrochloride Capsules 01)
FDA Label Image

The Following Table Shows The Frequency Of Treatment-related Side Effects Derived From Controlled Clinical Trials In Patients With Hypertension, Angina Pectoris, And Arrhythmia. These Patients Received Acebutolol, Propranolol, Or Hydrochlorothiazide As Monotherapy, Or Placebo. (Acebutolol Hydrochloride Capsules 02)

The Following Table Shows The Frequency Of Treatment-related Side Effects Derived From Controlled Clinical Trials In Patients With Hypertension, Angina Pectoris, And Arrhythmia. These Patients Received Acebutolol, Propranolol, Or Hydrochlorothiazide As Monotherapy, Or Placebo. (Acebutolol Hydrochloride Capsules 02)
FDA Label Image

The Incidence Of Drug-related Adverse Effects (volunteered And Solicited) According To Acebutolol Dose Is Shown Below. (data From 266 Hypertensive Patients Treated For 3 Months On A Constant Dose.) (Acebutolol Hydrochloride Capsules 03)

The Incidence Of Drug-related Adverse Effects (volunteered And Solicited) According To Acebutolol Dose Is Shown Below. (data From 266 Hypertensive Patients Treated For 3 Months On A Constant Dose.) (Acebutolol Hydrochloride Capsules 03)
FDA Label Image

Principal Display Panelndc 10135-0630-01acebutolol Hydrochloridecapsules, Usp200 mg100 Capsulesrx Only (Acebutolol Hydrochloride Capsules 04)

Principal Display Panelndc 10135-0630-01acebutolol Hydrochloridecapsules, Usp200 mg100 Capsulesrx Only (Acebutolol Hydrochloride Capsules 04)
FDA Label Image

Principal Display Panelndc 10135-0631-01acebutolol Hydrochloridecapsules, Usp400 mg100 Capsulesrx Only (Acebutolol Hydrochloride Capsules 05)

Principal Display Panelndc 10135-0631-01acebutolol Hydrochloridecapsules, Usp400 mg100 Capsulesrx Only (Acebutolol Hydrochloride Capsules 05)
This is a description of a medication labeled as NDC 10135-0631-01. Each capsule contains Acebutolol hydrochloride USP, which is equivalent to 400 mg of acebutolol. The manufacturer is Marlex Pharmaceuticals, Inc. The medication is for adult use only with the dosage specified in the package insert. It is important to keep this medication and all drugs out of the reach of children in a tightly closed, light-resistant container. It should be stored at 20° to 25°C (68° to 77°F) and protected from light. This medication should be given upon prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.